Information: Detta är inte den senaste versionen av datamodellen. Du hittar en versionsöversikt till vänster under versioner. Den senaste versionen hittar du här.
Information:
Fel:
ID
12905
Beskrivning
Pilot Clinical Trial of Pazopanib in Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML) or at Initial Diagnosis When no Intensive Treatment is Possible (PAZOPANIB-AML) https://clinicaltrials.gov/ct2/show/NCT01361334 Principal Investigator: PD Dr. Torsten Kessler, University Hospital Muenster, Germany
Länk
https://clinicaltrials.gov/ct2/show/NCT01361334
Nyckelord
Versioner (3)
- 2015-08-14 2015-08-14 - Martin Dugas
- 2016-01-05 2016-01-05 -
- 2016-02-11 2016-02-11 -
Uppladdad den
5 januari 2016
DOI
För en begäran logga in.
Licens
Creative Commons BY-NC 3.0 Legacy
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Agent AML Pazopanib NCT01361334
Agent AML Pazopanib NCT01361334
- StudyEvent: SE
Similar models
Agent AML Pazopanib NCT01361334
- StudyEvent: SE
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Patient ID (derived)
Item
Patient ID (derived)
text
C2348585 (UMLS CUI [1])
Gabe von Pazopanib: Blatt-Nummer
Item
Administration of Pazopanib: Page number
integer
C1704732 (UMLS CUI [1])
CL Item
yes (1)
Gabe von Pazopanib: Signatur - Datum
Item
Administration of Pazopanib: Signature date
date
C0807937 (UMLS CUI [1])
Item
Administration of Pazopanib: Signature date status
text
C2985875 (UMLS CUI [1])
Code List
Administration of Pazopanib: Signature date status
CL Item
T (1)
CL Item
TM (2)
CL Item
M (3)
Item
Administration of Pazopanib: Investigator Signature
text
C2346576 (UMLS CUI [1])
CL Item
ja (1)
CL Item
nein (0)
Kommentar Gabe Pazopanib
Item
Administration of Pazopanib: Comment
text
C0947611 (UMLS CUI [1])
Gabe von Pazopanib: Nummer
Item
Administration of Pazopanib: number
integer
C0806914 (UMLS CUI [1,1])
C1831796 (UMLS CUI [1,2])
C0750480 (UMLS CUI [1,3])
C1831796 (UMLS CUI [1,2])
C0750480 (UMLS CUI [1,3])
Medication start date
Item
Medication start date
date
C1521826 (UMLS CUI [1,1])
C0808070 (UMLS CUI [1,2])
C0808070 (UMLS CUI [1,2])
Item
Administration of Pazopanib: Start date status
text
C1444757 (UMLS CUI [1,1])
C1831796 (UMLS CUI [1,2])
C1831796 (UMLS CUI [1,2])
CL Item
T (1)
CL Item
TM (2)
CL Item
M (3)
Medication end date
Item
Medication end date
date
C1521826 (UMLS CUI [1,1])
C0806020 (UMLS CUI [1,2])
C0806020 (UMLS CUI [1,2])
Item
Administration of Pazopanib: end date status
text
C1444757 (UMLS CUI [1,1])
C1831796 (UMLS CUI [1,2])
C1831796 (UMLS CUI [1,2])
CL Item
T (1)
CL Item
TM (2)
CL Item
M (3)
Daily dose
Item
Daily dose
integer
C0178602 (UMLS CUI [1])
Item
Administration of Pazopanib: reason for change of dosage
text
C1299575 (UMLS CUI [1])
Code List
Administration of Pazopanib: reason for change of dosage
CL Item
Adverse Event (1)
C0877248 (UMLS CUI-1)
CL Item
Cyp3A4-Inhibitor (2)
C3850056 (UMLS CUI-1)
CL Item
Decision of patient (3)
C1389424 (UMLS CUI-1)
CL Item
other reason (4)
C0205394 (UMLS CUI-1)